Viva Biotech Holdings Statistics
Total Valuation
Viva Biotech Holdings has a market cap or net worth of HKD 1.29 billion. The enterprise value is 1.84 billion.
Market Cap | 1.29B |
Enterprise Value | 1.84B |
Important Dates
The next estimated earnings date is Friday, November 29, 2024.
Earnings Date | Nov 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Viva Biotech Holdings has 2.14 billion shares outstanding. The number of shares has increased by 7.22% in one year.
Shares Outstanding | 2.14B |
Shares Change (YoY) | +7.22% |
Shares Change (QoQ) | +0.06% |
Owned by Insiders (%) | 39.59% |
Owned by Institutions (%) | 1.25% |
Float | 1.04B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.57 |
PB Ratio | 0.32 |
P/FCF Ratio | 309.59 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.40, with an EV/FCF ratio of 443.73.
EV / Earnings | -5,390.38 |
EV / Sales | 0.86 |
EV / EBITDA | 4.40 |
EV / EBIT | 9.28 |
EV / FCF | 443.73 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 40.53.
Current Ratio | 1.65 |
Quick Ratio | 1.27 |
Debt / Equity | 40.53 |
Debt / EBITDA | 3.96 |
Debt / FCF | 398.92 |
Interest Coverage | 1.54 |
Financial Efficiency
Return on equity (ROE) is 0.83% and return on invested capital (ROIC) is 1.94%.
Return on Equity (ROE) | 0.83% |
Return on Assets (ROA) | 1.51% |
Return on Capital (ROIC) | 1.94% |
Revenue Per Employee | 1.05M |
Profits Per Employee | -167 |
Employee Count | 2,077 |
Asset Turnover | 0.26 |
Inventory Turnover | 5.26 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.49% in the last 52 weeks. The beta is 1.23, so Viva Biotech Holdings's price volatility has been higher than the market average.
Beta (5Y) | 1.23 |
52-Week Price Change | -53.49% |
50-Day Moving Average | 0.52 |
200-Day Moving Average | 0.65 |
Relative Strength Index (RSI) | 64.14 |
Average Volume (20 Days) | 2,113,300 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Viva Biotech Holdings had revenue of HKD 2.14 billion and -341,690 in losses. Loss per share was -0.10.
Revenue | 2.14B |
Gross Profit | 721.64M |
Operating Income | 198.43M |
Pretax Income | 99.73M |
Net Income | -341,690 |
EBITDA | 406.53M |
EBIT | 198.43M |
Loss Per Share | -0.10 |
Balance Sheet
The company has 1.11 billion in cash and 1.66 billion in debt, giving a net cash position of -542.81 million or -0.25 per share.
Cash & Cash Equivalents | 1.11B |
Total Debt | 1.66B |
Net Cash | -542.81M |
Net Cash Per Share | -0.25 |
Equity (Book Value) | 4.08B |
Book Value Per Share | 1.90 |
Working Capital | 819.85M |
Cash Flow
In the last 12 months, operating cash flow was 234.55 million and capital expenditures -230.40 million, giving a free cash flow of 4.15 million.
Operating Cash Flow | 234.55M |
Capital Expenditures | -230.40M |
Free Cash Flow | 4.15M |
FCF Per Share | 0.00 |
Margins
Gross margin is 33.66%, with operating and profit margins of 9.26% and -0.02%.
Gross Margin | 33.66% |
Operating Margin | 9.26% |
Pretax Margin | 4.65% |
Profit Margin | -0.02% |
EBITDA Margin | 18.96% |
EBIT Margin | 9.26% |
FCF Margin | 0.19% |
Dividends & Yields
Viva Biotech Holdings does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -7.22% |
Shareholder Yield | -7.22% |
Earnings Yield | -16.16% |
FCF Yield | 0.32% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |